Navigation Links
New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
Date:11/13/2007

Fast-dissolve method uses the latest advancement in aspirin delivery

technology.

CLEVELAND, Nov. 13 /PRNewswire/ -- Improvita Health Products, Inc. has rolled out Fasprin(R), a patented, 81 milligram aspirin tablet that dissolves rapidly in the mouth instead of in the stomach, offering an effective, simplified solution for the millions of Americans who maintain a daily aspirin routine and worry about gastrointestinal bleeding or swallowing pills.

A daily low-dose aspirin therapy is commonly prescribed to adults to prevent heart attack and stroke and help improve blood flow to the heart. Small daily doses of aspirin have proven to be effective in reducing the chances of mini-strokes (in which clogged blood vessels prevent sufficient oxygen from reaching the brain). Aspirin is also used to reduce the risk of heart attack in people with clogged coronary arteries, and in those who've already had an attack.

With its great-tasting "citrus burst" flavor, Fasprin is ideal for patients on a daily heart health aspirin regimen and is sugar free for diabetics.

Fasprin's patented, no-swallow aspirin delivery method reduces irritation to the gastrointestinal tract by quickly dissolving in the mouth, which allows the aspirin to enter the blood stream in just three to five minutes, or up to ten times faster than conventional aspirin that typically is absorbed through the stomach.

Tom Klamet, president of Improvita Health Products, Inc., noted that the low-dose aspirin tablet uses the latest technology for delivering the required dosage to the blood stream. "Fasprin was developed by a physician who saw the many benefits of an aspirin that could be administered quickly and effortlessly," he commented. "A daily aspirin regimen can fast become a chore, especially for older adults who have a hard time swallowing a full tablet. Fasprin's ability to dissolve on the tongue ensures 100 percent bioavailability, or the de
'/>"/>

SOURCE Improvita Health Products, Inc.
Copyright©2007 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine news :

1. New study: Pine bark reduces perimenopausal symptoms
2. Different method of evaluating the urinary tract system reduces radiation dose
3. Saline Reduces Mortality for Brain Injury Patients
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Radiation therapy technique reduces length of prostate cancer treatment
6. Radiation therapy technique reduces length of prostate cancer treatment
7. MR spectroscopy identifies breast cancer, reduces biopsies
8. Body-mind meditation boosts performance, reduces stress
9. Parkinsons Institute research shows that nicotine reduces levodopa-induced dyskinesias
10. VIDEO from Medialink and EcoQuest: New Technology Reduces Exposure to MRSA Staph
11. Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Recent Reviews In Major Peer Review Jo...t Promising New Developments For The Evidence-Base...g Difficulties. Some Of The Most Recent Are Listed...r 1, 2009 -- Review written by: Leesa V. Huang Ph....e 13, No. 3 November 2009. A nice synopsis of this...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to t...dica”) Board of Directors at the Company&rsq... (PRWEB) December 1, 2009 -- Anthony M. ...nologies , Inc. (“Stemedica”) Board of...ard Meeting. Roger J. Howe, PhD, Executive Chairma...
(Date:12/1/2009)... All Federal and Georgia State Retirees...nefits. This new benefit is part of the Medicare A...ivate fee for service (PFFS) Options offered by CI... Kaiser Permanente. Atlanta Hearing Associates has...A Lake Oconee / Greensboro, GA and Lake Sinclair /...
(Date:12/1/2009)...GAN, Minn., Dec. 1 "The patient wi...h care for Blue Cross and Blue Shield of Minnesota...ming the first Minnesotans - and the first in the ...nywhere(SM). Online Care Anywhere allows patients ... logging onto a computer or picking up the phone. ...
(Date:12/1/2009)..., SEATTLE, Dec. 1 Cel...management,s presentation at the 21st Annual Piper...er 1 at 11:00 a.m. Eastern Time will be webcast li...entation will take place in Holmes 1 at the New Yo...play after the presentation. , , ...
Breaking Medicine News(10 mins):Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3
...ional diabetes study of more than 52,000 patients ... BIAsp 30 insulin resulted in significant clinical... The findings, reported in the March issue of IJC...get set by the International Diabetes Foundation. ...
... Most Health Plan Members Drop Coverage for...nd Senior Management Commitment Are Necessary,to R... Orlando, FL (Vocus) March ...perly managing member disenrollment delivers a sig...
...March 2 Building on a proven track record of succ...e B. Richman today announced the U.S. Department o...eving a 75 percent participation rate in the Suppl... USDA once again for our efforts to ensure the bas...
...h 2 /PRNewswire-Asia/ -- Himfr.com,( http://www.h...B2B search,platforms with more than 30 B2B industr...oods to eat in spring. , Cherry: , Cherry ...w.himfr.com/buy-apple/ ), pear ( http://www.himf...
...orld Health Care Congress will feature the nation,...issues ranging from the impact of health reform un...nd practices that are shaping the delivery of care... for the most recent insights on health. , WHAT: ...
...arch 2 Herley Industries, Inc. (Nasdaq: HRLY ) ... has received contract awards totaling approximate...ufacture of complex integrated microwave assemblie...ts for use in the APG-68 radar system on various U...
Other Medicine News:Health News:Insulin drug study shows significant improvements in more than 52,000 diabetic patients 2Health News:Insulin drug study shows significant improvements in more than 52,000 diabetic patients 3Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 2Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 3Health News:Himfr.com Recommends Five Foods for Spring 2Health News:World Health Care Congress to convene preeminent leaders for 3 days on rebuilding health care 2Health News:Herley Lancaster Awarded $1.0 Million in New Contracts 2
(Date:11/30/2009)...C., Nov. 30 Microban International...l product protection, is pleased to announce their... Corp., the largest U.S. manufacturer and distribu...orp is launching two new lines of ceramic tile wit...;) patent pending silver based technology, in orde...
(Date:11/30/2009)...PRNewswire/ -- Breast-Specific Gamma Imaging (BSGI... technique for the detection of ductal carcinoma i...er. BSGI is a molecular breast imaging technique t...and discover very early stage cancers. According t...f the Radiological Society of North America (RSNA)...
(Date:11/30/2009)..., Nov. 30 SCOLR Pharma, ...vember 25, 2009, the NYSE Amex LLC (the "Exchange"...mpany,s plan to comply with its previously disclos... the Exchange Company Guide. Specifically, the de...losses which were so substantial in relation to it...
Breaking Medicine Technology:Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4University of Louisville neuroscientists hope to get people walking again 58667 1Experts gather at McGill University to address food security challenges 10216 1EPA reviews Univ of Michigan dioxin study 10212 1EPA reviews Univ of Michigan dioxin study 10212 2
... EnVivo Pharmaceuticals, Inc.,a privately held bio...egenerative diseases, today announced progress on ...chizophrenia and Huntington,s,diseases. EnVivo Ph...orally,active Alpha 7 Nicotinic Acetylcholine Rece...ts associated with Alzheimer,s disease and,Schizop...
...h Joint Venture Between Bristol-Myers Squibb, Co...n HIV Treatment -, PRINCETON, N.J. and FOSTER CIT...ol-Myers Squibb Company (NYSE: BMY ) and Gilead S...t Health Canada has approved ATRIPLA(R),(efavirenz...fumarate 300,mg) for the treatment of HIV-1 infect...
Other Medicine Technology:EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer's, Schizophrenia and Huntington's Diseases 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 2Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 3Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 4Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 5Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 6Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 7Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 8Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV 9
.../See™ is a 1-step, hand-held, point-of-care ...ug metabolites in human urine. The TOX/See device... drugs in 3 to 8 minutes and requires only a few d...ly packaged to maximize convenience and ease of us...
ESR-10 Manual Rack
...eck Cytometry Concentrate is for use as a sheath f...ach 70ml bottle of Cytometry Concentrate dilutes t...d to Cubitainers, Streck Cytometry Concentrate red...es money without compromising performance. Streck ...
CD-Chex CD34 Leukocyte Control
Medicine Products: